Gerratana, L., Angelis, C. D., Giudici, F., Torraca, A. L., Montesarchio, V., Gasparro, S., Biganzoli, L., Castellani, S., Sicari, E., Caltavituro, A., Foffano, L., Poletti, P. L., Corte, C. M. D., Ricciardi, G. R. R., Cairo, G., Gamucci, T., Mastro, L. D., Giuliano, M., Puglisi, F., Arpino, G. (2025). Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13068